10 February 2022

The strategic role of the English courts alongside the new Unified Patent Court

For decades the European Commission and EU member states have worked towards creating a pan-European Unified Patent Court (UPC). In August the German Constitutional Court issued a landmark decision taking us a step closer to this being a reality.  Recent developments mean that the UPC is now in its Provisional Application Period, and companies will be deciding how to use (or not to use) the new system.

The UK’s decision to leave the new system means that at some point the participating member states will need to reallocate some of the UK’s UPC responsibilities, in particular choosing a state to host the Central Division for life science disputes.

How will this decision impact the English courts, and what role will they play in European patent protection moving forward?

  1. Why did the UK choose to withdraw from the UPC?
  2. What role will the English courts play alongside the UPC?
  3. Will the UK remain a key venue for biopharma patent litigation?

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk